AstraZeneca drug cocktail succeeds in late-stage study to treat Covid-19
British pharmaceuticals giant AstraZeneca on Monday revealed more positive results from a trial of a treatment for Covid-19 symptoms.
The drug, made from a combination...
Pharmacy M&A deals jump 26 per cent last year as sector booms during pandemic
The number of mergers and acquisitions (M&A) deals in the UK pharmacy has risen 26 per cent to 408 in the last year from...
Boots report points to a new era of digital healthcare services
The largest pharmacy-led health and beauty chain in the UK, Boots, has launched a new report that reveals increasing popularity of digital healthcare services...
Morningside Pharmaceuticals’ Nik Kotecha named in top 50 most ambitious business leaders list
Dr Nik Kotecha, chairman of Morningside Pharmaceuticals, has been named in the LDC’s Top 50 Ambitious Business Leaders for 2021 list.
The list, which is...
Alliance Healthcare owner AmerisourceBergen supports Covid-19 vaccines distribution worldwide
American pharmaceutical wholesaler AmerisourceBergen, which owns Alliance Healthcare, has supported the distribution of more than 75 million Covid-19 vaccines across 30-plus countries through its...
‘South Asians least likely to recognise cancer symptoms’
People from South Asian communities are less likely to recognize cancer symptoms which could prevent them from seeking lifesaving help from their GPs, new...
NHS announces new treatment for sickle cell, seals deal with Novartis
For the first time in two decades, a new therapy with life-saving benefits will be made available on the NHS to treat patients with...
Revalidation: Pharmacists need to file only reflective account until February 2022
Pharmacists and pharmacy technicians due to submit their revalidation records from December 2021 only need to present a reflective account until February 2022, the...
RPS signs charter for climate action, calls it a ‘vital collaboration’
The Royal Pharmaceutical Society(RPS) has signed a charter designed to guide effective and high-quality climate action by professional bodies in the UK.
The charter launched...
NICE recommends updacitinib to treat moderate rheumatoid arthritis
NICE has recommended a combination of updacitinib and methotrexate as an option to treat moderate active rheumatoid arthritis in adults, who responded inadequately to...
Current Issue March 2024
